Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels

200293 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 13, Issue 8, pp. 1259-1263

Field-Weighted Citation Impact: 10.32